« Back
Home /
Bid BH3 Peptide

Bid BH3 Peptide

Manufacturer	GenScript
Category	Oncology By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Peptides & Proteins Cell Biology Cell Status Apoptosis Myelofibrosis Autophagy Cardiovascular Research Ischemia & Reperfusion Injury Peptides By Organ Colorectal Cancer Testicular & Prostate Cancer
Type	Peptides
Specific against	other
Amount	1mg
Item no.	RP20440
Targets	ASXL1, BCL2
eClass 6.1	34160400
eClass 9.0	32160409
Available
Description	BID is a pro-apoptotic member of the BH3-only (BOPS) subset of the BCL-2 family of proteins that constitute a critical control point in apoptosis. Bid is the first of the BOPs reported to bind and activate Bcl-2, Bax, and Bak. Bid serves as a death-inducing ligand that moves from the cytosol to the mitochondrial membrane to inactivate Bcl-2 or to activate Bax.
Storage	Store the peptide at -20C.
Product Origin	USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

RP20440-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 5/16/2024